CLINICAL ROLE -
Sodium-Glucose Cotransporter-2 Inhibitors for Treating Type 2 Diabetes
Diabetes is a complex disease affecting 29.1 million individuals in the United States.
Use of Neprilysin Inhibitors in Chronic Heart Failure
Heart failure contributes to significant morbidity and mortality in the United States.
Approximately 73.5 million adults in the United States have a high level of low-density lipoprotein cholesterol.
Rapivab was approved by the FDA in December 2014 to treat acute and uncomplicated influenza in adults.
Influenza Antiviral Therapies
During the 2013-2014 influenza season, the influenza vaccination prevented approximately 7.2 million illnesses and 90,000 influenza-associated hospitalizations.
Novel Oral Anticoagulants
Anticoagulants are used frequently to treat and prevent thromboembolism. Historically, vitamin K antagonists have been the standard of care and only oral option.
Orkambi is a new combination medication to treat cystic fibrosis in patients 12 years and older who are homozygous for the F508del mutation on the CF transmembrane conductance regulator CFTR gene.
Isavuconazonium sulfate (Cresemba) is a new antifungal medication indicated for the treatment of invasive forms of aspergillosis and mucormycosis in patients at least 18 years of age.
2 Clarke Drive Cranbury, NJ 08512